284 related articles for article (PubMed ID: 20858979)
41. P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta.
Tai LM; Loughlin AJ; Male DK; Romero IA
J Cereb Blood Flow Metab; 2009 Jun; 29(6):1079-83. PubMed ID: 19367293
[TBL] [Abstract][Full Text] [Related]
42. PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice.
Wang H; Chen F; Zhong KL; Tang SS; Hu M; Long Y; Miao MX; Liao JM; Sun HB; Hong H
Br J Pharmacol; 2016 Jan; 173(2):372-85. PubMed ID: 26507867
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
44. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
[TBL] [Abstract][Full Text] [Related]
45. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
[TBL] [Abstract][Full Text] [Related]
46. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
[TBL] [Abstract][Full Text] [Related]
47. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
48. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism.
Chikhale EG; Burton PS; Borchardt RT
J Pharmacol Exp Ther; 1995 Apr; 273(1):298-303. PubMed ID: 7714780
[TBL] [Abstract][Full Text] [Related]
49. Influence of P-glycoprotein on brucine transport at the in vitro blood-brain barrier.
Xu DH; Yan M; Li HD; Fang PF; Liu YW
Eur J Pharmacol; 2012 Sep; 690(1-3):68-76. PubMed ID: 22749978
[TBL] [Abstract][Full Text] [Related]
50. Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier.
Ito S; Ohtsuki S; Terasaki T
Neurosci Res; 2006 Nov; 56(3):246-52. PubMed ID: 16926058
[TBL] [Abstract][Full Text] [Related]
51. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
[TBL] [Abstract][Full Text] [Related]
52. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.
Lamartinière Y; Boucau MC; Dehouck L; Krohn M; Pahnke J; Candela P; Gosselet F; Fenart L
J Alzheimers Dis; 2018; 64(4):1195-1211. PubMed ID: 30010117
[TBL] [Abstract][Full Text] [Related]
53. On the in vivo early toxic properties of A-beta 25-35 peptide in the rat hippocampus: involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression.
Cuevas E; Lantz SM; Tobón-Velasco JC; Newport GD; Wu Q; Virmani A; Ali SF; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):288-96. PubMed ID: 21216281
[TBL] [Abstract][Full Text] [Related]
54. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses.
Businaro R; Leone S; Fabrizi C; Sorci G; Donato R; Lauro GM; Fumagalli L
J Neurosci Res; 2006 Apr; 83(5):897-906. PubMed ID: 16477616
[TBL] [Abstract][Full Text] [Related]
55. EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model.
Wan WB; Cao L; Liu LM; Kalionis B; Chen C; Tai XT; Li YM; Xia SJ
PLoS One; 2014; 9(11):e113126. PubMed ID: 25426944
[TBL] [Abstract][Full Text] [Related]
56. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.
Jaeger LB; Dohgu S; Sultana R; Lynch JL; Owen JB; Erickson MA; Shah GN; Price TO; Fleegal-Demotta MA; Butterfield DA; Banks WA
Brain Behav Immun; 2009 May; 23(4):507-17. PubMed ID: 19486646
[TBL] [Abstract][Full Text] [Related]
57. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
[TBL] [Abstract][Full Text] [Related]
58. Aβ
Chan Y; Chen W; Wan W; Chen Y; Li Y; Zhang C
Exp Cell Res; 2018 Aug; 369(2):266-274. PubMed ID: 29856989
[TBL] [Abstract][Full Text] [Related]
59. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
60. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.
Mruthinti S; Buccafusco JJ; Hill WD; Waller JL; Jackson TW; Zamrini EY; Schade RF
Neurobiol Aging; 2004 Sep; 25(8):1023-32. PubMed ID: 15212827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]